India’s Enforcement Directorate opened an investigation into the BBC in April 2023 under the Foreign Exchange Management Act, two months after tax authorities searched the broadcaster’s offices in Delhi and Mumbai
Tax authorities raided the BBC’s New Delhi office in February 2023
By Eastern EyeFeb 26, 2025
INDIA’S financial crime fighting agency has fined the BBC £314,510 for alleged foreign exchange violations in the country, three government sources told Reuters.
The agency, India’s Enforcement Directorate (ED), opened an investigation into the BBC in April 2023 under the Foreign Exchange Management Act, two months after tax authorities searched the broadcaster’s offices in Delhi and Mumbai.
The ED conducts investigations into suspected contraventions of India’s Foreign Exchange Management Act and can “adjudicate and impose penalties” on those found guilty, according to its website.
The BBC, which launched a new company for Indian language services in December 2023, was issued a show-cause notice earlier that year for failing to reduce foreign ownership in the firm to the permitted limit of 26 per cent, the sources said.
As a result, the broadcaster has been fined £314,510, along with a fine for every day since October 15, 2021 for violations.
Additionally, three directors of the company have each been fined £104,836 for their roles in overseeing operations during the period of contravention, the sources added.
The BBC said it had not received a so-called adjudication order yet. “We will carefully review any order when it is received and consider next steps as appropriate,” the BBC said in a statement.
The tax raids in February 2023 followed the release of a BBC documentary about India’s prime minister Narendra Modi’s leadership of the state of Gujarat during riots in 2002.
The Indian government had in 2023 dismissed the documentary as “propaganda”, blocked its airing and also barred sharing of any clips via social media in the country.
A nurse walks through an alley at the Government Medical College, where children were admitted after consuming Coldrif cough syrup, which has been linked to the deaths of multiple children, in Nagpur, India, October 8, 2025.
INDIAN police have arrested the owner of a pharmaceutical company after a cough syrup made at his plant was linked to the deaths of at least 21 children, officials said on Thursday.
Most of the children, all under the age of five, died in Madhya Pradesh over the past month after being prescribed the syrup, which was found to be contaminated with a toxic substance.
Cough syrups manufactured in India have come under global scrutiny in recent years following deaths in several countries linked to their consumption. The incidents have affected India’s reputation as the world’s third-largest producer of drugs and pharmaceuticals by volume.
G. Ranganathan, 75, was arrested early on Thursday at his home in Chennai by police teams from Chennai and Madhya Pradesh.
He was charged with culpable homicide not amounting to murder and adulteration of drugs, police sources told AFP and Indian media reported.
The syrup, sold under the brand name Coldrif, was manufactured by Sresan Pharma at a unit in Tamil Nadu.
The Indian health ministry said on Saturday that tests on samples showed contamination with diethylene glycol (DEG), a toxic chemical used in industrial solvents that can be fatal even in small quantities.
Authorities in Madhya Pradesh and several other states have banned the product.
Indian media reported that the World Health Organization had asked Indian officials for clarification on whether the contaminated syrup had been exported to other countries.
In 2022, more than 70 children died in Gambia from acute kidney failure after consuming a cough syrup imported from India.
Between 2022 and 2023, 68 children in Uzbekistan died after consuming another contaminated syrup made in India.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.